2/18/2013

More than a fifth of stable diabetes patients examined showed slight elevations in cardiac troponin I levels and had a 50% increased risk of major adverse cardiac events over three years, researchers found. The results, published in Diabetes Care, "imply that any detectable cTnI level should warrant consideration for more globally aggressive risk-reduction efforts, including closer evaluation and long-term monitoring, and such intervention efforts may focus beyond glycemic-control measures," said researcher Dr. W.H. Wilson Tang.

Related Summaries